Breast Cancer Clinical Trials

Showing 2941-2960 of 4,817 trials

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

NCT03295695

This is a single arm, phase 0 study to evaluate the safety and efficacy of PET-CT scans with FDG-labeled RBC in patients with breast cancer. Cardiac ejection fraction can be calculated and monitored in breast cancer patients during chemotherapy using a FDG-RBC PET-CT scan. The purpose of this study is to determine if calculated cardiac ejection fraction shows high concordance with results from echocardiography.

Breast CancerBreast Cancer, FemaleBreast Cancer, Male+1 more

H. Lee Moffitt Cancer Center and Research InstituteStarted Dec 2020

Tampa, Florida, United States

COMPLETEDPhase 1/2

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

NCT00290745

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen or letrozole may fight breast cancer by blocking the use of estrogen by the tumor cells or by lowering the amount of estrogen the body makes. PURPOSE: This clinical trial is studying how well tamoxifen or letrozole work in treating women with ductal carcinoma in situ.

Breast Cancer

University of California, San Francisco79 participantsStarted Feb 2002

San Francisco, California, United States

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

Related Searches

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM)

Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer

Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer

Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -

Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care

Reducing Metabolic Syndrome Among Breast Cancer Survivors

Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer

18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?

An Observational Study of Herceptin SC Safety in Breast Cancer

Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer

Improving Brain Function After Breast Cancer Study

Cultivando la Salud: A Breast and Cervical Cancer Screening Promotion Program for Low-Income Puerto Rican Women

Long-term Improvement of Quality of Life in Breast Cancer Patients With Quality of Life Diagnosis and Therapy

The ConnectedCancerCare Pilot Study (CCC)